The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-up-Reference-Cited by-同舟云学术

The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-up

Published:2015-12-19 Issue:10 Volume:31 Page:1609-1615
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Yano Hideki,Horinaka Shigeo,Ishikawa Mayuko,Ishimitsu Toshihiko

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-015-0783-9.pdf

Reference25 articles.

1. Horst B, Rihal CS, Holmes DR Jr, Bresnahan JF, Prasad A, Gau G, Lennon R, Lerman A (2009) Comparison of drug-eluting and bare-metal stents for stable coronary artery disease. JACC Cardiovasc Interv 2:321–328

2. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network metaanalysis. Lancet 370:937–948

3. van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, Koolen JJ, Brueren BR, Dambrink JH, Hautvast RW, Verheugt FW, ten Berg JM (2009) Predictors of coronary stent thrombosis: the Dutch Stent thrombosis registry. J Am Coll Cardiol 53:1399–1409

4. Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AJ, Cristea E, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Möeckel M, Stone GW, Harmonizing Outcomes With Revascularization Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Investigators (2011) Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 123:1745–1756

5. Stone GW, Parise H, Witzenbichler B, Kirtane A, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Lansky AJ, Mehran R (2010) Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 56(19):1597–1604

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year outcomes after first- and second-generation drug-eluting stent implantation in all patients undergoing percutaneous coronary intervention;Journal of Cardiology;2019-08

2. Comparison of the vessel healing process after everolimus-eluting stent and bare metal stent implantations in patients with ST-elevation myocardial infarction;Heart and Vessels;2018-11-03

3. Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis;Chinese Medical Journal;2018-03-05

4. Initial and late efficacy of everolimus-eluting stents for small and non-small coronary lesions from evaluating delayed late loss study;Heart and Vessels;2017-07-07

5. Impact of Killip classification on acute myocardial infarction: data from the SAIKUMA registry;Heart and Vessels;2017-07-05